The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents
Basic Information
Publication number:
EP2652491
WO Application Number:
US2011064962
Type:
European Patent Granted for NL
Status:
Patent in Force
Publication Title:
Title When Made Available For Viewing:
Reason Lapsed:
Application number:
EP11813477.4
WO Publication Number:
WO2012082933
EPO Publication Language:
English
SPC Number:
First Applicant Residence Country:
Switzerland (CH)
Publications:
Dates
Filing date:
14/12/2011
Grant date:
29/11/2017
EP Publication Date:
23/10/2013
WO Publication Date:
21/06/2012
Claims Translations Received Date:
Claims Translation B1 Received Date:
19/02/2018
Claims Translation B2 Received Date:
Claims Translation B3 Received Date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Published:
Due To Cession Date:
Registration date:
29/11/2017
EP B1 Publication Date:
29/11/2017
EP B2 Publication Date:
EP B3 Publication Date:
Description Translation B1 Received Date:
Description Translation B2 Received Date:
Description Translation B3 Received Date:
Expiration date:
13/12/2031
Lapsed By Expiration Date:
Patent Validated Date:
03/03/2018
Revocation Date:
Invalidity Date:
Response To Novelty Search Report Received:
Patent Granting Request:
Lapsed date:
Applicant/holder
From:
22/12/2021
Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome,
Chuo-ku,
Osaka-shi, Osaka, Japan (JP)
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995 in respect of which a decision has been taken. Oppositon(s) decisions ex European Patent Convention
3
Bulletin Heading:
VB1
Journal edition number:
41/18
Publication date:
03/10/2018
Description:
Requests for restoration and notices of objection, notices of appeal to Court, notices of appeal to Council of State ex NL Patent Law 1995. Opposition(s) filed ex European Patent Convention
4
Bulletin Heading:
EP3
Journal edition number:
11/18
Publication date:
07/03/2018
Description:
European patents granted for the Netherlands in which a translation was filed ex Article 52 par. 1 of the NL Patent Law 1995
5
Bulletin Heading:
EP2
Journal edition number:
48/17
Publication date:
29/11/2017
Description:
European patents granted for the Netherlands
European Patent Bulletin
1
Issue number:
202141
Publication date:
13/10/2021
Description:
Opposition rejected; Patent maintained as granted
2
Issue number:
201840
Publication date:
03/10/2018
Description:
Opposition procedure started
3
Issue number:
201748
Publication date:
29/11/2017
Description:
Grant (B1)
Deed
Change of Address
Change Kind/ Decision Type:
Owner
Deed Number:
RC202102720A
Date Registered:
22/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & McKenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Changed Pledgee
Name:
Address:
Removed Usufructuary
Name:
Address:
Added Usufructuary
Name:
Address:
Changed Usufructuary
Name:
Address:
Change of owner(s)
Change Kind/ Decision Type:
Assignment
Deed Number:
RC202102720B
Date Registered:
22/12/2021
License Effective Date:
License Expiration Date:
Scope of License:
Deed Filer:
Baker & McKenzie Amsterdam N.V.
Journal Edition Number:
Text:
Deed Status:
Country Code:
Updated License Number:
Terminated License Number:
Added Owner(s)
Name:
Takeda Pharmaceutical Company Limited
Address:
1-1, Doshomachi 4-chome,
Chuo-ku,
Osaka-shi, Osaka, Japan (JP)